Find verified Odalasvir API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Odalasvir for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Odalasvir API.
Alternate Names: Dimethyl ((2S,2'S)-((2S,2'S,3aS,3a'S,7aS,7a'S)-(1,4(1,4)-dibenzenacyclohexaphane-12,43-diylbis(1H-benzo[d]imidazole-6,2-diyl))bis(octahydro-1H-indole-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate, Carbamic acid, N,N'-(tricyclo(8.2.2.24,7)hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis(1H-benzimidazole-6,2-diyl((2S,3aS,7aS)-octahydro-1H-indole-2,1-diyl)((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,C'-dimethyl ester
CAS No: 1415119-52-6
PubChem CID: 71474517
Mol Formula: C60H72N8O6
Mol Weight: 1001.3 g/mol
IUPAC Name: methyl N-[(2S)-1-[(2S,3aS,7aS)-2-[6-[11-[2-[(2S,3aS,7aS)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-2-yl]-3H -Show More
API Description: Odalasvir is an investigational drug that is an NS5A inhibitor, meaning it blocks a protein in the hepatitis C virus (HCV) that is crucial for viral replication. It was developed by Achillion Pharmaceuticals for the treatment of hepatitis C, a liver infection caused by the virus.
